WEREWOLF THERAPEUTICS INC HOWL
COM · Common Stock · CUSIP 95075A107
- SectorHealth care
- IndustryPharmaceutical Preparations
- HeadquartersWaltham, MA
- FilingsSEC EDGAR
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Shares outstanding: 27.7m as of 2022-03-18, from the company's own SEC filing; the percentage can still exceed 100%: lent-out shares are counted by the lender and the buyer, and some reports overlap without saying so. Implied quarter-end price ≈ $4.43. Options: 1 managers hold calls ($0 notional), 1 hold puts ($0).
Trends to Q1 2022
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q2 2021 | 46 |
| Q3 2021 | 43 |
| Q4 2021 | 52 |
| Q1 2022 | 50 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q3 2021 | 17 | 17 |
| Q4 2021 | 31 | 9 |
| Q1 2022 | 21 | 23 |
Biggest buyers
| PFM Health Sciences, LP | Added | +185.3k |
| FMR LLC | Added | +147.9k |
| STATE STREET CORP | Added | +75.5k |
| GEODE CAPITAL MANAGEMENT, LLC | Added | +74.1k |
| MILLENNIUM MANAGEMENT LLC | New | +42.4k |
| Granite Point Capital Management, L.P. | Added | +40.0k |
| Evercore Wealth Management, LLC | Added | +25.0k |
| CITADEL ADVISORS LLC | New | +20.1k |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | Added | +15.1k |
| DC Funds, LP | Added | +8.2k |
Biggest sellers
| Avidity Partners Management LP | Sold out | -485.0k |
| Soleus Capital Management, L.P. | Sold out | -64.6k |
| SPHERA FUNDS MANAGEMENT LTD. | Reduced | -64.2k |
| CAAS CAPITAL MANAGEMENT LP | Reduced | -61.0k |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | Sold out | -23.7k |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | Sold out | -12.8k |
| JPMORGAN CHASE & CO | Reduced | -12.4k |
| MetLife Investment Management, LLC | Sold out | -11.4k |
| Metropolitan Life Insurance Co/NY | Sold out | -8.5k |
| UBS Group AG | Reduced | -7.4k |
Biggest calls
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | New | $00 shares |
Biggest puts
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | New | $00 shares |
Options at notional value: the value of the shares the contracts control, as filers report them, not what the options cost. Not included in the holders, shares or buying above.
Major shareholders (over 5%)
Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.
| Holder | Stake |
|---|---|
| MOLL PETER 13G · exempt (held before listing) new · filed 2026-09-21 | 5.2% |
Fell to 5% or below in the last year: RA CAPITAL MANAGEMENT, L.P. (4.1%, 2026-07-02), MPM BioVentures 2014, L.P. (3.8%, 2026-05-12), Longwood Fund III, L.P. (3.5%, 2026-02-11)
Insider purchases and sales in Q1 2022
Shares bought or sold by the company's own officers, directors and 10% owners, in the open market or privately, as they reported to the SEC on Form 4 (due within two business days of the trade). Grants, option exercises, shares withheld for tax and gifts aren't included.
Officers and directors buying vs selling
Number of people, by quarter (10% owners not included)
Numbers
| Quarter | Buying | Bought | Selling | Sold | Sold under a plan |
|---|---|---|---|---|---|
| Q2 2020 | 0 | — | 0 | — | — |
| Q3 2020 | 0 | — | 0 | — | — |
| Q4 2020 | 0 | — | 0 | — | — |
| Q1 2021 | 0 | — | 0 | — | — |
| Q2 2021 | 4 | $45.4m | 0 | — | — |
| Q3 2021 | 0 | — | 0 | — | — |
| Q4 2021 | 0 | — | 1 | $40.2k | — |
| Q1 2022 | 0 | — | 0 | — | — |
None reported in Q1 2022.
Holders, Q1 2022
| Manager | Shares | Change |
|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. 0.41% of their portfolio | 4.3m $18.9m | Unchanged |
| MPM ASSET MANAGEMENT LLC 6.44% of their portfolio | 4.3m $18.9m | Unchanged |
| MPM BIOIMPACT LLC 2.82% of their portfolio | 2.4m $10.5m | Unchanged |
| BlackRock Inc. 0.00% of their portfolio | 1.3m $5.6m | Added +7.3k |
| ADAGE CAPITAL PARTNERS GP, L.L.C. 0.01% of their portfolio | 975.6k $4.3m | Added +15.1k |
| DEERFIELD MANAGEMENT COMPANY, L.P. 0.09% of their portfolio | 958.1k $4.2m | Unchanged |
| DC Funds, LP 33.68% of their portfolio | 589.1k $2.6m | Added +8.2k |
| PFM Health Sciences, LP 0.10% of their portfolio | 585.3k $2.6m | Added +185.3k |
| SPHERA FUNDS MANAGEMENT LTD. 0.43% of their portfolio | 584.2k $2.6m | Reduced -64.2k |
| VANGUARD GROUP INC 0.00% of their portfolio | 522.1k $2.3m | Reduced -5.5k |
| FMR LLC 0.00% of their portfolio | 518.6k $2.3m | Added +147.9k |
| STATE STREET CORP 0.00% of their portfolio | 335.1k $1.5m | Added +75.5k |
| GEODE CAPITAL MANAGEMENT, LLC 0.00% of their portfolio | 288.3k $1.3m | Added +74.1k |
| PLATINUM INVESTMENT MANAGEMENT LTD 0.03% of their portfolio | 213.4k $939.0k | Unchanged |
| Alyeska Investment Group, L.P. 0.01% of their portfolio | 206.2k $907.0k | Unchanged |
| NORTHERN TRUST CORP 0.00% of their portfolio | 195.1k $859.0k | Reduced -5.0k |
| Migdal Insurance & Financial Holdings Ltd. 0.01% of their portfolio | 187.5k $825.0k | Unchanged |
| CAAS CAPITAL MANAGEMENT LP 0.08% of their portfolio | 101.6k $447.0k | Reduced -61.0k |
| Bank of New York Mellon Corp 0.00% of their portfolio | 68.3k $301.0k | Added +3.6k |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC 0.00% of their portfolio | 60.6k $267.0k | Added +52 |
| Granite Point Capital Management, L.P. 0.12% of their portfolio | 55.0k $242.0k | Added +40.0k |
| Evercore Wealth Management, LLC 0.00% of their portfolio | 46.5k $205.0k | Added +25.0k |
| MILLENNIUM MANAGEMENT LLC 0.00% of their portfolio | 42.4k $187.0k | New |
| Nuveen Asset Management, LLC 0.00% of their portfolio | 36.9k $731.0k | Unchanged |
| RHUMBLINE ADVISERS 0.00% of their portfolio | 22.6k $99.0k | Added +3.2k |
| BANK OF AMERICA CORP /DE/ 0.00% of their portfolio | 22.3k $98.0k | Reduced -5.9k |
| CITADEL ADVISORS LLC 0.00% of their portfolio | 20.1k $89.0k | New |
| JPMORGAN CHASE & CO 0.00% of their portfolio | 15.6k $68.0k | Reduced -12.4k |
| TWO SIGMA INVESTMENTS, LP 0.00% of their portfolio | 15.2k $67.0k | Reduced -6.9k |
| DEUTSCHE BANK AG\ 0.00% of their portfolio | 14.3k $63.0k | Reduced -1.7k |
| NEW YORK STATE COMMON RETIREMENT FUND 0.00% of their portfolio | 14.1k $62.0k | Added +189 |
| AMERICAN INTERNATIONAL GROUP, INC. 0.00% of their portfolio | 13.1k $58.0k | Reduced -923 |
| GOLDMAN SACHS GROUP INC 0.00% of their portfolio | 11.7k $51.0k | Added +1.6k |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM 0.00% of their portfolio | 11.3k $50.0k | Reduced -3.1k |
| MORGAN STANLEY 0.00% of their portfolio | 7.6k $33.0k | Reduced -433 |
| WELLS FARGO & COMPANY/MN 0.00% of their portfolio | 5.7k $26.0k | Reduced -7.0k |
| BARCLAYS PLC 0.00% of their portfolio | 4.3k $19.0k | New |
| AMALGAMATED BANK 0.00% of their portfolio | 3.9k $17.0k | New |
| Amalgamated Financial Corp. 0.00% of their portfolio | 3.9k $17.0k | First filing |
| Tower Research Capital LLC (TRC) 0.00% of their portfolio | 2.7k $12.0k | Added +2.1k |
| CITIGROUP INC 0.00% of their portfolio | 2.7k $12.0k | Reduced -5.2k |
| Legal & General Group Plc 0.00% of their portfolio | 2.6k $11.0k | Added +121 |
| UBS Group AG 0.00% of their portfolio | 2.1k $9.0k | Reduced -7.4k |
| Ameritas Investment Partners, Inc. 0.00% of their portfolio | 2.0k $9.0k | Unchanged |
| STRS OHIO 0.00% of their portfolio | 1.8k $7.0k | Unchanged |
| ROYAL BANK OF CANADA 0.00% of their portfolio | 1.6k $7.0k | Reduced -4.1k |
| OLIVER LAGORE VANVALIN INVESTMENT GROUP 0.00% of their portfolio | 580 $3.0k | New |
| Financial Perspectives, Inc 0.00% of their portfolio | 250 $1.1k | Unchanged |
| Daiwa Securities Group Inc. 0.00% of their portfolio | 80 $0 | Unchanged |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0.00% of their portfolio | 0 $0 | Unchanged |